This is a lively discussion about novel excipients with an introduction provided by the FDA. Our panelists share insights on both the industry need for novel excipients as well as their thoughts on the FDA's Novel Excipient Review Pilot Program.

Track: Quality & Regulatory

Presentation Level: Fundamental (requires little or no previous knowledge of the topic)

Target Audience by Industry Segment:
> Pharmaceutical - Generic Drugs
> Pharmaceutical - Originator Drugs
> Biologics - Biotech Drugs (Originators)
> Biologics - Biosimilars (Follow on Biologics)
> Veterinary Medicine
> Medical Device / Combination Products
> Consumer Goods (Medical Products)

Target Audience by Role:
> Formulations
> Research & Development
> Quality
> Regulatory

Note: Presentations are available for on-demand viewing for 21 days after purchase.